APA

Weiss G. J., Infante J. R., Chiorean E. G., Borad M. J., Bendell J. C., Molina J. R., Tibes R., Ramanathan R. K., Lewandowski K., Jones S. F., Lacouture M. E., Langmuir V. K., Lee H., Kroll S. & Burris H. A. (20110915). Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Weiss Glen J, Infante Jeffrey R, Chiorean E Gabriela, Borad Mitesh J, Bendell Johanna C, Molina Julian R, Tibes Raoul, Ramanathan Ramesh K, Lewandowski Karen, Jones Suzanne F, Lacouture Mario E, Langmuir Virginia K, Lee Hank, Kroll Stew and Burris Howard A. 20110915. Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Weiss G. J., Infante J. R., Chiorean E. G., Borad M. J., Bendell J. C., Molina J. R., Tibes R., Ramanathan R. K., Lewandowski K., Jones S. F., Lacouture M. E., Langmuir V. K., Lee H., Kroll S. and Burris H. A. (20110915). Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Weiss Glen J, Infante Jeffrey R, Chiorean E Gabriela, Borad Mitesh J, Bendell Johanna C, Molina Julian R, Tibes Raoul, Ramanathan Ramesh K, Lewandowski Karen, Jones Suzanne F, Lacouture Mario E, Langmuir Virginia K, Lee Hank, Kroll Stew and Burris Howard A. Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20110915.